Shelton Capital Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $291K | Hold |
3,677
| – | – | 0.01% | 562 |
|
|
2026
Q1 | $317K | Hold |
3,677
| – | – | 0.01% | 492 |
|
|
2025
Q4 | $321K | Sell |
3,677
-267
| -7% | -$20.3K | 0.01% | 472 |
|
|
2025
Q3 | $226K | Hold |
3,944
| – | – | ﹤0.01% | 632 |
|
|
2025
Q2 | $233K | Hold |
3,944
| – | – | 0.01% | 603 |
|
|
2025
Q1 | $289K | Hold |
3,944
| – | – | 0.01% | 488 |
|
|
2024
Q4 | $326K | Hold |
3,944
| – | – | 0.01% | 468 |
|
|
2024
Q3 | $282K | Hold |
3,944
| – | – | 0.01% | 532 |
|
|
2024
Q2 | $270K | Hold |
3,944
| – | – | 0.01% | 531 |
|
|
2024
Q1 | $212K | Hold |
3,944
| – | – | 0.01% | 696 |
|
|
2023
Q4 | $210K | Buy |
+3,944
| New | +$192K | 0.01% | 677 |
|
|
2023
Q3 | – | Sell |
-3,944
| Closed | -$235K | – | 715 |
|
|
2023
Q2 | $235K | Hold |
3,944
| – | – | 0.01% | 621 |
|
|
2023
Q1 | $223K | Hold |
3,944
| – | – | 0.01% | 627 |
|
|
2022
Q4 | $293K | Sell |
3,944
-263
| -6% | -$17.9K | 0.03% | 440 |
|
|
2022
Q3 | $251K | Hold |
4,207
| – | – | 0.01% | 526 |
|
|
2022
Q2 | $236K | Hold |
4,207
| – | – | 0.01% | 594 |
|
|
2022
Q1 | $310K | Hold |
4,207
| – | – | 0.01% | 530 |
|
|
2021
Q4 | $304K | Hold |
4,207
| – | – | 0.01% | 552 |
|
|
2021
Q3 | $322K | Hold |
4,207
| – | – | 0.01% | 525 |
|
|
2021
Q2 | $326K | Hold |
4,207
| – | – | 0.01% | 534 |
|
|
2021
Q1 | $259K | Hold |
4,207
| – | – | 0.01% | 626 |
|
|
2020
Q4 | $274K | Sell |
4,207
-278
| -6% | -$16K | 0.01% | 533 |
|
|
2020
Q3 | $222K | Hold |
4,485
| – | – | 0.01% | 650 |
|
|
2020
Q2 | $214K | Buy |
+4,485
| New | +$216K | 0.01% | 573 |
|
|
2020
Q1 | – | Sell |
-5,100
| Closed | -$300K | – | 726 |
|
|
2019
Q4 | $300K | Hold |
5,100
| – | – | 0.02% | 524 |
|
|
2019
Q3 | $261K | Sell |
5,100
-332
| -6% | -$15.8K | 0.02% | 599 |
|
|
2019
Q2 | $230K | Buy |
5,432
+5,164
| +1,927% | +$224K | 0.01% | 700 |
|
|
2019
Q1 | $5.43K | Sell |
268
-5,164
| -95% | -$234K | 0.02% | 556 |
|
|
2018
Q4 | $235K | Hold |
5,432
| – | – | 0.02% | 607 |
|
|
2018
Q3 | $308K | Hold |
5,432
| – | – | 0.02% | 575 |
|
|
2018
Q2 | $274K | Hold |
5,432
| – | – | 0.02% | 622 |
|
|
2018
Q1 | $271K | Hold |
5,432
| – | – | 0.02% | 608 |
|
|
2017
Q4 | $223K | Buy |
+5,432
| New | +$190K | 0.01% | 761 |
|
Other funds holding GMED
JT
SC
Shelton Capital Management's GMED Position: Q2 2026 in Review
Shelton Capital Management held its Globus Medical (GMED) position steady in Q2 2026 at 3,677 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #562.
Shelton Capital Management first reported a position in GMED in Q4 2017 and has held it in 33 quarters since. The position peaked at $326K in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Shelton Capital Management held 3,677 shares of Globus Medical worth $291K as of Q2 2026.
- Shelton Capital Management left its Globus Medical share count unchanged in Q2 2026.
- Globus Medical made up 0.01% of Shelton Capital Management's portfolio in Q2 2026, its #562 holding.
- Shelton Capital Management first reported a position in Globus Medical in Q4 2017 and has held it in 33 quarters since.
- Shelton Capital Management's Globus Medical position peaked at $326K in Q4 2024.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.